EDITOR-IN-CHIEF

Picture of Prof Dr Claus Jacob, B.Sc. M.A. D.Phil. (Oxon) FRSC CChem

Prof Dr Claus Jacob, B.Sc. M.A. D.Phil. (Oxon) FRSC CChem

Saarland University, Saarbruecken, Germany

Claus Jacob B.Sc. M.A. D.Phil. (Oxon) FRSC CChem, has been a Full Professor at Saarland University since 2011. He is the Head of Bioorganic Chemistry at the School of Pharmacy, Saarland University. Prof Jacob completed his B.Sc. in Chemistry at the University of Leicester in 1993, followed by a D.Phil. from the University of Oxford in 1997, and later earned a Magister Artium in Philosophy from the University of Hagen in 1998.

His research interests encompass reactive sulfur and selenium species, bioorganic chemistry, drug design, and redox regulation via cellular thiolstat. Prof Jacob is known for his contributions in the areas of Reactive Sulfur Species, Sensor/Effector catalysts in drug design, Cellular Thiolstat, and Intracellular Diagnostics. He has authored over 200 publications in these fields and is a Fellow of The Royal Society of Chemistry.

Prof Jacob is also engaged in the philosophy of science, contributing to ethics, sociology, and history of science. He is an advocate for green chemistry and ethical scientific practices, and is a member of the International Society of Philosophy of Chemistry.

EDITORIAL BOARD MEMBERS

Picture of Prof. Dr. Eufrânio da Silva Júnior, PhD

Prof. Dr. Eufrânio da Silva Júnior, PhD

Federal University of Minas Gerais, Brazil

Eufrânio N. da Silva Júnior obtained his PhD in Chemistry at the University of Brasília in 2009. In 2010, he started his independent career as Professor at the Federal University of Minas Gerais (UFMG). His recent awards and distinctions include RSC/BMOS Young Investigator Award (2015), MedChemComm New Talent: Americas (2017), Themed collection “Contributors to the emerging investigators issue 2018” of Chemical Society Reviews, CNPq-SBQ-RSC Brazilian Chemistry Certificate of Distinction (2019), Elected Affiliate Member of the Brazilian Academy of Sciences (2020) and Fellow of the Royal Society of Chemistry (2023). He was visiting Professor at Bristol University, Universität Göttingen – Georg-August-Universität Göttingen and Indian Institute of Technology Bombay. He has more than 140 publications related to Organic Chemistry and Medicinal Chemistry.

Research interests: Catalysis and synthesis of heterocyclic; quinoidal bioactive and fluorescent compounds; transition metal catalysed C–H activation reactions; single step reactions to produce trypanocidal naphthoquinoidal compounds: iodination, oxygenation, alkenylation, thiolation and selenation processes; electrochemistry; nanocatalysis.

Picture of Dr. Muhammad Jawad Nasim, PhD

Dr. Muhammad Jawad Nasim, PhD

Saarland University, Saarbruecken, Germany

Dr. Muhammad Jawad Nasim completed his Pharm.D (Doctor of Pharmacy) degree at Bahauddin Zakariya University, Multan, Pakistan, in 2011. Following his graduation, he served as a Research Associate at the Department of Pharmaceutical Sciences, COMSATS University of Science and Technology, Abbottabad Campus, Pakistan until 2013. In pursuit of further academic endeavors, Dr. Nasim joined the research group led by Prof Dr Claus Jacob at the School of Pharmacy, Saarland University, Saarbruecken, Germany, in 2013. He initially pursued a Diplom of Pharmacy and later advanced his studies, culminating in the attainment of a doctoral degree in 2019. Since completing his doctorate, Dr. Nasim has remained actively engaged in scholarly pursuits, assuming the roles of a Postdoctoral Scholar and Senior Administrator within the research group.

Research interests: Reactive sulfur species; reactive selenium species; redox modulation; drug design; medicinal chemistry; Natural products; nutraceuticals.

Picture of Dr. Yaman Abdin, PhD

Dr. Yaman Abdin, PhD

Saarland University, Saarbruecken, Germany

Dr. Ahmad Yaman Abdin is a postdoctoral researcher at the Institute for Bioorganic Chemistry, Saarland University, Germany.  His research focuses on the relation between science and society, specifically pharmacy. This includes the social aspects of drug design, pharmacy and the environment and pharmacy and public health.
Research interests: Natural products; Nutraceuticals; Policy; Pharmacy; Public health; Waste Management

Picture of Prof. Chukwunonso E.C.C. Ejike, PhD

Prof. Chukwunonso E.C.C. Ejike, PhD

Alex Ekwueme Federal University, Ndufu-Alike, Ebonyi State, Nigeria

Chukwunonso E.C.C. Ejike, PhD, is a Professor of Medical Biochemistry. Prof. Ejike was trained up to the doctorate level at the University of Nigeria, Nsukka and had his postdoctoral training at the University of Guelph, Ontario, Canada. He has benefitted from short-term fellowships in Germany, and trainings in South Africa and India. He currently has eighteen years of teaching and research experience; and to his credit are more than a hundred peer-reviewed scientific publications in some of the best journals in his field; more than fifty conference presentations; six scientific books and edited volumes; six non-scientific books; two technical reports; and dozens of articles in the print and electronic media. His highly cited scientific publications and literary outputs validate the notion of complementary muses. He has held a number of administrative positions in the university, including serving in the Governing Council of the University. 

Research interests:  Clinical nutrition; natural products chemistry. 

Picture of Dr. Enrique Domínguez-Álvarez, PhD

Dr. Enrique Domínguez-Álvarez, PhD

Institute of General Organic Chemistry, of the Spanish National Research Council (IQOG-CSIC), Spain

Enrique Domínguez-Álvarez, PhD, embarked on his current role in 2017 as a Tenured Staff Scientist at the Institute of General Organic Chemistry (IQOG) of the Spanish National Research Council (CSIC) in Madrid, Spain. Dr. Domínguez-Álvarez focuses on synthesizing sulfur and selenium derivatives as innovative anticancer and antibacterial agents. Additionally, his research delves into the development of inhibitors targeting mechanisms associated with cancer and bacterial resistance, such as efflux pumps. With a diverse academic background, Dr. Domínguez-Álvarez completed his PhD in Organic and Medicinal Chemistry at the University of Navarra in Spain in 2012. During this time, he specialized in the synthesis of chemopreventive and antiproliferative selenocompounds. Subsequently, he pursued a PhD internship at Saarland University in Germany, followed by postdoctoral positions at Jagiellonian University Medical College in Poland and the Kazan Federal University in Tatarstan. His postdoctoral research focused on various aspects, including the synthesis of novel ligands for the Histamine H4 receptor and the search for inhibitors of the ABCB1 efflux pump, as well as the synthesis of micro- and nano-particles of metal oxides as catalysts in in situ oil-upgrading processes. Dr. Domínguez-Álvarez’s multidisciplinary expertise and commitment to advancing medicinal chemistry have positioned him as a leader in the field.

Research interests: Selenium; cancer research; medicinal chemistry; multidrug resistance; antibiotics; selenium chemistry; antioxidants.

Picture of Dr. Małgorzata Anna Marć, PhD

Dr. Małgorzata Anna Marć, PhD

Organic Chemistry Center of the Spanish National Research Council (CENQUIOR-CSIC), Spain

Małgorzata Anna Marć earned her PhD in Pharmaceutical Sciences from Jagiellonian University Medical College (Kraków, Poland) with a focus on pharmaceutical biotechnology in 2019. During this time, she conducted research in cancer biology, drug discovery, and the ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicology) aspects of potential drug candidates. Her work also involved the application of alternative methods in drug safety and metabolism. With experience spanning four countries—Spain, Poland, Hungary, and Italy—and positions in both academia and industry, Dr. Marć has gained a comprehensive understanding of scientific research in biomedicine and drug discovery. Among her various areas of expertise, she is particularly adept at pharmacological and ADMET evaluation of novel organic compounds, with a focus on their potential as anticancer and antimicrobial agents. Selenocompounds and hydantoins are two classes of compounds in which she has developed significant proficiency. Driven by a passion for cutting-edge research, Dr. Marć is eager to continue tackling new challenges in cancer research and biomedicine. She believes these areas hold tremendous potential for making meaningful contributions to scientific advancement.

Research interests: Cancer research; ADMET, selenium; pharmaceutical biotechnology; drug discovery & design; multidrug resistance; pharmacology; microbiology.

Picture of Dr. Serhii Holota, PhD

Dr. Serhii Holota, PhD

Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

Serhii Holota is a Ukrainian Pharmacist, with MSc and PhD degrees (Pharmacy) obtained in 2000 and 2006, respectively. He currently serves as an Associate Professor in the Department of Pharmaceutical, Organic, and Bioorganic Chemistry at Danylo Halytsky Lviv National Medical University, as well as in the Department of Organic and Pharmaceutical Chemistry at Lesya Ukrainka Volyn National University.

Research interests: Medicinal and organic chemistry; synthetic and natural heterocyclic compounds.  

Scroll to Top